Suppr超能文献

中国大陆放弃“动态清零”政策后对 COVID-19 死亡人数的预估。

Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy.

机构信息

Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA.

Department of Medicine, Stanford University, Stanford, California, USA.

出版信息

Eur J Clin Invest. 2023 Apr;53(4):e13956. doi: 10.1111/eci.13956. Epub 2023 Jan 27.

Abstract

BACKGROUND

China witnessed a surge of Omicron infections after abandoning 'zero COVID' strategies on 7 December 2022. The authorities report very sparse deaths based on very restricted criteria, but massive deaths are speculated.

METHODS

We aimed to estimate the COVID-19 fatalities in Mainland China until summer 2023 using the experiences of Hong Kong and of South Korea in 2022 as prototypes. Both these locations experienced massive Omicron waves after having had very few SARS-CoV-2 infections during 2020-2021. We estimated age-stratified infection fatality rates (IFRs) in Hong Kong and South Korea during 2022 and extrapolated to the population age structure of Mainland China. We also accounted separately for deaths of residents in long-term care facilities in both Hong Kong and South Korea.

RESULTS

Infection fatality rate estimates in non-elderly strata were modestly higher in Hong Kong than South Korea and projected 987,455 and 619,549 maximal COVID-19 deaths respectively, if the entire China population were infected. Expected COVID-19 deaths in Mainland China until summer 2023 ranged from 49,962 to 691,219 assuming 25-70% of the non-elderly population being infected and variable protection of elderly (from none to three-quarter reduction in fatalities). The main analysis (45% of non-elderly population infected and fatality impact among elderly reduced by half) estimated 152,886-249,094 COVID-19 deaths until summer 2023. Large uncertainties exist regarding potential changes in dominant variant, health system strain and impact on non-COVID-19 deaths.

CONCLUSIONS

The most critical factor that can affect total COVID-19 fatalities in China is the extent to which the elderly can be protected.

摘要

背景

2022 年 12 月 7 日,中国放弃“动态清零”政策后,奥密克戎感染病例激增。当局根据非常有限的标准报告了非常少的死亡人数,但据推测死亡人数巨大。

方法

我们旨在使用香港和韩国在 2022 年的经验作为原型,估算 2023 年夏季之前中国大陆的 COVID-19 死亡人数。这两个地区在 2020-2021 年期间感染 SARS-CoV-2 病例很少之后,都经历了大规模的奥密克戎浪潮。我们估算了香港和韩国在 2022 年的年龄分层感染病死率(IFR),并将其外推至中国大陆的人口年龄结构。我们还分别考虑了香港和韩国长期护理设施中居民的死亡人数。

结果

在非老年人群中,香港的感染病死率略高于韩国,分别预测如果中国全部人口感染,最大 COVID-19 死亡人数为 987455 人和 619549 人。假设非老年人口中有 25-70%的人感染,老年人的保护程度(从无到致命病例减少四分之三)不同,中国大陆 2023 年夏季之前预计 COVID-19 死亡人数在 49962 至 691219 人之间。主要分析(45%的非老年人口感染,老年人的病死率降低一半)估计 2023 年夏季之前有 152886-249094 人死于 COVID-19。潜在的主要变体变化、卫生系统压力和对非 COVID-19 死亡的影响存在很大的不确定性。

结论

影响中国 COVID-19 总死亡人数的最关键因素是老年人能够得到多大程度的保护。

相似文献

1
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy.
Eur J Clin Invest. 2023 Apr;53(4):e13956. doi: 10.1111/eci.13956. Epub 2023 Jan 27.
2
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy.
medRxiv. 2023 Jan 13:2022.12.29.22284048. doi: 10.1101/2022.12.29.22284048.
5
Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
Emerg Infect Dis. 2022 Sep;28(9):1856-1858. doi: 10.3201/eid2809.220613. Epub 2022 Aug 1.
8
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
Emerg Infect Dis. 2022 Feb;28(2):460-462. doi: 10.3201/eid2802.212422. Epub 2021 Dec 3.
9
COVID-19 and Long-Term Care Policy for Older People in Hong Kong.
J Aging Soc Policy. 2020 Jul-Oct;32(4-5):373-379. doi: 10.1080/08959420.2020.1773192. Epub 2020 May 31.
10
Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12575-12578. doi: 10.26355/eurrev_202012_24054.

引用本文的文献

1
Healthcare professionals' perceptions of system preparedness during public health emergencies: a path analysis of mental health impacts.
Front Public Health. 2025 Apr 17;13:1449207. doi: 10.3389/fpubh.2025.1449207. eCollection 2025.
2
A Cohort Study of the Long-Term Influences of SARS-CoV-2 on Kidney Allograft Outcomes in Chinese Recipients: 1-Year Follow-Up Experience.
Kidney Dis (Basel). 2025 Feb 12;11(1):128-142. doi: 10.1159/000543935. eCollection 2025 Jan-Dec.
4
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study.
Bone Marrow Transplant. 2025 May;60(5):587-594. doi: 10.1038/s41409-025-02525-1. Epub 2025 Feb 21.
6
Efficacy of Azvudine Therapy in Patients with Severe and Non-Severe COVID-19: A Propensity Score-Matched Analysis.
Infect Drug Resist. 2024 Oct 7;17:4317-4325. doi: 10.2147/IDR.S481591. eCollection 2024.
8
The association of calligraphy activities with peace of mind, stress self-management, and perceived health status in older adults.
Front Psychol. 2024 Sep 9;15:1455720. doi: 10.3389/fpsyg.2024.1455720. eCollection 2024.
9
The spatiotemporal analysis of SARS-CoV-2 transmission in China since the termination of the dynamic zero-COVID policy.
Virol Sin. 2024 Oct;39(5):737-746. doi: 10.1016/j.virs.2024.09.003. Epub 2024 Sep 11.

本文引用的文献

3
The impact of ending 'zero COVID' in China.
Nat Med. 2023 Feb;29(2):302. doi: 10.1038/d41591-023-00001-1.
4
The WHO estimates of excess mortality associated with the COVID-19 pandemic.
Nature. 2023 Jan;613(7942):130-137. doi: 10.1038/s41586-022-05522-2. Epub 2022 Dec 14.
5
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
BMC Med. 2022 Nov 23;20(1):451. doi: 10.1186/s12916-022-02655-z.
7
Age-stratified infection fatality rate of COVID-19 in the non-elderly population.
Environ Res. 2023 Jan 1;216(Pt 3):114655. doi: 10.1016/j.envres.2022.114655. Epub 2022 Oct 28.
8
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.
Lancet Infect Dis. 2022 Oct;22(10):1435-1443. doi: 10.1016/S1473-3099(22)00345-0. Epub 2022 Jul 15.
9
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Lancet Reg Health Eur. 2022 Sep;20:100453. doi: 10.1016/j.lanepe.2022.100453. Epub 2022 Jul 1.
10
Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations.
Environ Res. 2022 Oct;213:113754. doi: 10.1016/j.envres.2022.113754. Epub 2022 Jun 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验